آسيا · أخبار عامة · China Daily

Wuxi-developed cancer drug reaches US market

نشره China Daily · الصين منذ 10 س

D3 Bio is advancing four drug candidates through global clinical trials, while Abogen Biosciences signed a licensing agreement with Swiss pharmaceutical giant Novartis in October,…

اقرأ المقال كاملًا على China Daily سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (global.chinadaily.com.cn)

يستحق القراءة أيضًا

The Straits Times

Trump says Oval Office to become national monument

Philippine Daily Inquirer

First of 25 witnesses for Sara Duterte defense backs out

Times of India

Texas Farm Funds Scholarships: Donated land backs Gruver High students; many are first-generation grads

Yonhap

Melania Trump calls for lasting peace after brokering local Russia-Ukraine ceasefire

CNA

From star maps to meteorites: 9 watches that bring the cosmos to your wrist

มติชน Matichon